Primary application study in early diagnosis of bladder cancer by survivin molecular beacons
- PMID: 17656209
- DOI: 10.1016/j.urology.2007.03.023
Primary application study in early diagnosis of bladder cancer by survivin molecular beacons
Abstract
Objectives: To develop a sensitive method for the detection of bladder cancer cells in the urine castoff cells of patients with bladder cancer, we examined the feasibility of using molecular beacon (MB) probes specific for tumor-specific survivin mRNA.
Methods: MBs are single-stranded oligonucleotide hybridization probes that form a stem-and-loop structure and have high sensitivity and specificity. Western blot analysis showed that a high level of survivin gene expression is detected in human bladder cancer 5637 and J82 cell lines but not in normal human prostate fibroblast cells. These cell lines were incubated with survivin MBs, and the fluorescence intensity was examined in those cells using a fluorescence microscope.
Results: We found that survivin MBs could detect expression of the survivin gene and generated fluorescent signals in the cancer cells. However, the fluorescence signal was not detected in the normal prostate fibroblast cells. The green fluorescent signal was present in the exfoliated cells of patients with bladder cancer but not in the healthy adult after incubating with survivin MBs.
Conclusions: Our results have demonstrated that the survivin MB is a specific and sensitive molecular probe for detecting bladder cancer cells and urine castoff cells of patients with bladder cancer. It has great potential for the development of a clinical diagnostic procedure for the early detection of bladder cancer and follow-up after surgery.
Similar articles
-
Preliminary study of diagnostic utility of molecular beacons in bladder cancer.Urology. 2010 Aug;76(2):512.e8-13. doi: 10.1016/j.urology.2010.04.023. Epub 2010 Jun 25. Urology. 2010. PMID: 20579701
-
Detection of survivin expression in cervical cancer cells using molecular beacon imaging: new strategy for the diagnosis of cervical cancer.Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):204-8. doi: 10.1016/j.ejogrb.2011.06.038. Epub 2011 Jul 12. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21752529
-
Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.J Urol. 2006 Jun;175(6):2312-6. doi: 10.1016/S0022-5347(06)00254-0. J Urol. 2006. PMID: 16697865
-
Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.Clin Chim Acta. 2006 Jun;368(1-2):20-32. doi: 10.1016/j.cca.2005.12.036. Epub 2006 Feb 9. Clin Chim Acta. 2006. PMID: 16480698 Review.
-
Bladder cancer detection using FISH (UroVysion assay).Adv Anat Pathol. 2008 Sep;15(5):279-86. doi: 10.1097/PAP.0b013e3181832320. Adv Anat Pathol. 2008. PMID: 18724101 Review.
Cited by
-
Molecular beacons: a novel optical diagnostic tool.Arch Immunol Ther Exp (Warsz). 2013 Apr;61(2):139-48. doi: 10.1007/s00005-012-0209-7. Epub 2013 Jan 5. Arch Immunol Ther Exp (Warsz). 2013. PMID: 23292078 Free PMC article. Review.
-
Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells.Acta Pharmacol Sin. 2011 Dec;32(12):1522-8. doi: 10.1038/aps.2011.122. Epub 2011 Oct 24. Acta Pharmacol Sin. 2011. PMID: 22019956 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous